PARP1 and cancer: These findings raise the possibility that the combined use of conventional chemotherapeutic agents, which cause oxidative stress in normal tissues67, and PARP inhibitors, may contribute to premature cellular senescence and aging in cancer patients through a telomere-mediated mechanism.